Hologic, Inc. (NASDAQ:HOLX)
| CAPS Rating |
|
|---|---|
| Open | $20.71 |
| Previous Close | $20.92 |
| Daily Range | $20.48 - $20.79 |
| 52-Week Range | $13.90 - $23.24 |
| Market Cap | $5.43B |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,031,039 |
| Average Daily Volume | 0 |
HOLX
VS S&P 500 (SPY)
How do you think HOLX will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
HOLX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
HOLX News and Commentary
- Something Worth Watching at Hologic – The Motley Fool
- Earnings Scorecard: Hologic - Analyst Blog – NASDAQ
- 1 Reason Hologic Looks Weak – The Motley Fool
- Hologic Tops Estimates - Analyst Blog – NASDAQ
- Hologic Outruns Estimates Again – The Motley Fool
- Opening View: Futures are Down Amid Ongoing Greece Stability Concerns – NASDAQ
- Does Boston Scientific Pass Buffett's Test? – The Motley Fool
- Several Setbacks for Conceptus - Analyst Blog – NASDAQ
- 2012 Preview: K-V Pharmaceuticals – The Motley Fool
- A No-Good, Really Bad, Awful Year for This Pharmaceutical Company – The Motley Fool
- Here's How Varian Medical Systems Is Making You So Much Cash – The Motley Fool
- FDA Nod for Hologic's Cervista HTA - Analyst Blog – NASDAQ
- Cepheid Stays Neutral - Analyst Blog – NASDAQ
- Conceptus Lowers 2011 Guidance - Analyst Blog – NASDAQ
- 1 Reason Gen-Probe's Earnings Aren't So Hot – The Motley Fool
- Gen-Probe Passes This Key Test – The Motley Fool
- IsoRay Begins GliaSite Shipment - Analyst Blog – NASDAQ
- Here's How Hologic Is Making You So Much Cash – The Motley Fool
- 1 Reason Hologic May Be Headed for a Slowdown – The Motley Fool
- Hologic Launches C-View Software - Analyst Blog – NASDAQ
RSS Headlines
Fool UK
